Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with German health claims data
- PMID: 26848277
- PMCID: PMC4723096
- DOI: 10.2147/IJWH.S89468
Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with German health claims data
Abstract
Objective: To evaluate the economic and clinical benefits of endometrial radiofrequency ablation (RFA) compared with other ablation techniques for the treatment of menorrhagia.
Methods: Using German health claims data, women meeting defined inclusion criteria for the intervention group (RFA) were selected. A comparable control group (other endometrial ablations) was established using propensity score matching. These two groups were compared during the quarter of treatment (QoT) and a follow-up of 2 years for the following outcomes: costs during QoT and during follow-up, repeated menorrhagia diagnoses during follow-up and necessary retreatments during follow-up.
Results: After performing propensity score matching, 50 cases could be allocated to the intervention group, while 38 were identified as control cases. Patients in the RFA group had 5% fewer repeat menorrhagia diagnoses (40% vs 45%; not significant) and 5% fewer treatments associated with recurrent menorrhagia (6% vs 11%; not significant) than cases in the control group. During the QoT, the RFA group incurred €578 additional costs (€2,068 vs €1,490; ns). However, during follow-up, the control group incurred €1,254 additional costs (€4,561 vs €5,815; ns), with medication, outpatient physician consultations, and hospitals costs being the main cost drivers. However, none of the results were statistically significant.
Conclusion: Although RFA was more cost-intensive in the QoT compared with other endometrial ablation techniques, an average total savings of €676 was generated during the follow-up period. While having evidence that RFA is clinically equivalent to other endometrial ablation procedures, we generated indications that RFA is non-inferior and favorable with regard to economic outcomes.
Keywords: Germany; costs; endometrial ablation; health claims data; menorrhagia; radiofrequency ablation.
Figures
Similar articles
-
Economic and clinical benefits of radiofrequency ablation versus hysterectomy in patients suffering from menorrhagia: a retrospective analysis with German health claims data.Expert Rev Med Devices. 2015 May;12(3):365-72. doi: 10.1586/17434440.2015.1015988. Epub 2015 Feb 23. Expert Rev Med Devices. 2015. PMID: 25702818
-
Long-term economic evaluation of resectoscopic endometrial ablation versus hysterectomy for the treatment of menorrhagia.J Am Assoc Gynecol Laparosc. 1998 Nov;5(4):351-6. doi: 10.1016/s1074-3804(98)80046-7. J Am Assoc Gynecol Laparosc. 1998. PMID: 9782137
-
Economic evaluation of hysteroscopic endometrial ablation versus vaginal hysterectomy for menorrhagia.Obstet Gynecol. 1996 Aug;88(2):241-5. doi: 10.1016/0029-7844(96)00150-0. Obstet Gynecol. 1996. PMID: 8692509
-
Health technology assessment of surgical therapies for benign gynaecological disease.Best Pract Res Clin Obstet Gynaecol. 2006 Dec;20(6):841-79. doi: 10.1016/j.bpobgyn.2006.11.006. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 17145485 Review.
-
Meta-analysis of bipolar radiofrequency endometrial ablation versus thermal balloon endometrial ablation for the treatment of heavy menstrual bleeding.Int J Gynaecol Obstet. 2018 Jan;140(1):3-10. doi: 10.1002/ijgo.12340. Epub 2017 Nov 9. Int J Gynaecol Obstet. 2018. PMID: 28984905 Review.
Cited by
-
Health economic evaluations based on routine data in Germany: a systematic review.BMC Health Serv Res. 2018 Apr 10;18(1):268. doi: 10.1186/s12913-018-3080-3. BMC Health Serv Res. 2018. PMID: 29636046 Free PMC article.
-
Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.BMC Womens Health. 2022 Jun 27;22(1):257. doi: 10.1186/s12905-022-01843-6. BMC Womens Health. 2022. PMID: 35761328 Free PMC article.
References
-
- National Collaborating Centre for Women’s and Children’s Health . Heavy menstrual bleeding – clinical guideline. London: RCOG Press; 2007.
-
- Duckitt K. Managing perimenopausal menorrhagia. Maturitas. 2010;66(3):251–256. - PubMed
-
- Bourdrez P, Bongers MY, Mol BW. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Fertil Steril. 2004;82(1):160–166. - PubMed
-
- Lethaby A, Penninx J, Hickey M, Garry R, Marjoribanks J. Endometrial resection and ablation techniques for heavy menstrual bleeding (review) Cochrane Database Syst Rev. 2013;8:CD001501. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous